COMPARISON OF SURVIVAL OUTCOMES OF RECURRENT GLIOBLASTOMA PATIENTS: A COMPARISON BETWEEN PATIENTS ENROLLED INTO CLINICAL TRIALS AND PATIENTS THAT DID NOT ENROLL INTO TRIALS AT FIRST PROGRESSION

被引：0
|
作者：
Balasubramanian, Geethanjali [1 ]
Yerramothu, Shruti [2 ]
Youssef, Gilbert [3 ]
Lee, Eudocia [2 ]
Castro, Luis Nicolas Gonzalez [3 ]
McFaline-Figueroa, Jose Ricardo [3 ]
Nayak, Lakshmi [2 ]
Reardon, David [3 ]
Trippa, Lorenzo [2 ]
Wen, Patrick [4 ]
Rahman, Rifaquat [5 ]
机构：
[1] Boston Univ, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
[4] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[5] Dana Farber Brigham & Womens Canc Ctr, Dept Radiat Oncol, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
INNV-16
引用
收藏
页数：1
相关论文
共 50 条
  • [41] An Analysis of Japanese Patients Enrolled in Multiregional Clinical Trials in Oncology
    Hirakawa, Akihiro
    Kinoshita, Fumie
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (02) : 207 - 211
  • [42] Letter concerning "Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival": Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma
    Di Nunno, Vincenzo
    Gatto, Lidia
    Tosoni, Alicia
    Bartolini, Stefania
    Franceschi, Enrico
    NEURO-ONCOLOGY, 2023, 25 (08) : 1546 - 1547
  • [43] Comparison of survival endpoints in glioblastoma patients receiving or not receiving enzyme-inducing anticonvulsants in NCCTG Trials.
    Jaeckle, KA
    Ballman, K
    Uhm, J
    O'Fallon, J
    Schomberg, P
    Scheithauer, B
    Giannini, C
    Flynn, PJ
    Buckner, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 113S - 113S
  • [44] "You Gotta Troll to Enroll!" Nurses Actively Scouting Patients for Clinical Trials
    Robertson, Betty
    Levesque, Denise
    Wolber, Nicole
    Steiner, Nili
    Nunez, Nancy
    Guerra, Sonia
    Paletz, Laurie
    STROKE, 2020, 51
  • [45] Changes in survival and time to progression in metastatic breast cancer (MBC) patients enrolled into clinical trials from 1983 to 2001.
    Gennari, A
    Conte, P
    Orlandini, C
    Guarneri, V
    Rosso, R
    Bruzzi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 35S - 35S
  • [46] Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
    Bachelot, T
    Ray-Coquard, I
    Catimel, G
    Ardiet, C
    Guastalla, JP
    Dumortier, A
    Chauvin, F
    Droz, JP
    Philip, T
    Clavel, M
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 151 - 156
  • [47] Characterization and outcomes of patients enrolled to multiple phase I cancer trials
    Kuehne, Nathan
    Chen, Lina
    McDonald, Kate
    Wang, Lisa
    Spreafico, Anna
    Hansen, Aaron
    Razak, Albiruni Ryan Abdul
    Bedard, Philippe Lucien
    Siu, Lillian L.
    Shepshelovich, Daniel
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (02) : 469 - 472
  • [48] Characterization and outcomes of patients enrolled to multiple phase I cancer trials
    Nathan Kuehne
    Lina Chen
    Kate McDonald
    Lisa Wang
    Anna Spreafico
    Aaron Hansen
    Albiruni Ryan Abdul Razak
    Philippe Lucien Bedard
    Lillian L. Siu
    Daniel Shepshelovich
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 469 - 472
  • [49] Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes
    Menzella, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [50] Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials
    Malik, Laeeq
    Parsons, Helen
    Mahalingam, Devalingam
    Ehler, Benjamin
    Goros, Martin
    Mejia, Alex
    Brenner, Andrew
    Sarantopoulos, John
    CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : 359 - 365
12345